PharmaCyte Biotech Creates Faster Path to the Clinic for Company's Diabetes Treatment
May 20, 2015 09:30 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - May 20, 2015) - PharmaCyte Biotech (OTCQB: PMCB) has managed to do something that is rarely done in science -- bring together an international group of leading experts to...
Independence Blue Cross helps employees walk to better health at National Walk @ Lunch Day
April 29, 2015 14:30 ET
|
Independence Blue Cross
PHILADELPHIA, April 29, 2015 (GLOBE NEWSWIRE) -- For the eighth consecutive year, Independence Blue Cross (Independence) celebrated National Walk @ Lunch Day, a national effort sponsored by the Blue...
Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc.
November 03, 2014 10:49 ET
|
Nuvilex, Inc.
SYDNEY, AUSTRALIA--(Marketwired - November 03, 2014) - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be...
Type 2 Diabetes Trial Results Presented by Study Investigators at American Diabetes Association Annual Meeting
June 18, 2014 23:19 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, June 18, 2014 (GLOBE NEWSWIRE) -- Results from the Phase 2 trial of Mesoblast's proprietary adult stem cells in type 2 diabetes patients have been presented by Jay...
Independence Blue Cross study in Journal of Public Health Management and Practice: reduced medical costs for diabetics treated in medical homes
May 01, 2014 11:16 ET
|
Independence Blue Cross
PHILADELPHIA, PA., May 1, 2014 (GLOBE NEWSWIRE) -- Results from a three-year study by Independence Blue Cross (Independence) demonstrating reduced medical costs for diabetic patients cared for by...
Independence Blue Cross recognizes National Walk @ Lunch Day
April 30, 2014 14:54 ET
|
Independence Blue Cross
PHILADELPHIA, April 30, 2014 (GLOBE NEWSWIRE) -- Today, Independence Blue Cross (Independence) recognizes National Walk @ Lunch Day, a national effort sponsored by the Blue Cross and Blue Shield...
Hydraulic Fracturing, Dietary Supplement Safety, and Nanomaterials in Food Are All Topics at Upcoming Toxicology Conference
February 24, 2014 08:06 ET
|
Society of Toxicology
RESTON, VA, VA., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Nobel Laureate Sir John B. Gurdon, DPhil, DSc, FRS, will kick off the largest gathering of toxicologists in the world when he delivers a lecture on...
Sirona Biochem to Present Scientific Poster at Canadian Diabetes Professional Conference
October 04, 2012 13:20 ET
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 4, 2012) - Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB), a biotechnology company specializing in carbohydrate...
Sirona Biochem Announces Primate Results for SGLT Inhibitor for Type 2 Diabetes
June 20, 2012 09:00 ET
|
Sirona Biochem Corp.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 20, 2012) - Sirona Biochem Corp. (TSX VENTURE:SBM)(PINKSHEETS:SRBCF)(FRANKFURT:ZSB), announced today results from a preclinical study of...
VIDEO From GI Dynamics and Synaptic Digital: Select U.K. Centres Offer New Treatment for Type 2 Diabetes
June 11, 2012 03:00 ET
|
Synaptic Digital a Definition 6 Company
LEXINGTON, Mass. and BERKSHIRE, England, June 11, 2012 (GLOBE NEWSWIRE) -- Diabetes affects 3.7 million people in the United Kingdom (U.K.) and another 7 million people are currently at risk for...